Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Why Type One Diabetes Patients Need Closed Loop Insulin Systems

For a while now there has been a heated debate surrounding hybrid and closed loop insulin systems.

Read More »

Olympus unit pleads guilty to resolve U.S. duodenoscope probe

An Olympus Corp. subsidiary pleaded guilty and agreed to pay $85 million to resolve charges of failure to file reports with U.S. regulators regarding infections connected to its duodenoscopes while continuing to sell the medical devices used to view the gastrointestinal tract.

Read More »

Top Trends in Digital Health in 2019

2018 was the year of the consumer, and there is no sign of a change any time soon.

Read More »

Impel NeuroPharma Closes $67.5 Million Series D to Advance CNS Portfolio

Seattle-based Impel NeuroPharma closed on a Series D financing totaling $67.5 million, co-led by KKR and Northwest Venture Partners.

Read More »

Medtronic Will Pay $51 Million To Settle DOJ Investigation Against Two Company Acquisitions

Medtronic will pay a total of nearly $51 million to resolve three legal claims against Covidien Plc and ev3 Inc., two companies that are now part of the Ireland-based medtech company. Medtronic itself had no role in the wrongdoings that resulted in the multi-million fines.

Read More »

FDA picks eight medical device firms to help battle opioid crisis

Eight medical device makers – including a startup that uses virtual reality to treat chronic pain – topped an innovation contest aimed at addressing the opioid crisis, the U.S. FDA said.

Read More »

Health stocks up on U.S. vote, insurers hit records

Healthcare stocks rallied with U.S. health insurers reaching record highs as results of the 2018 mid-term elections were seen reducing the likelihood of action to cut medical costs and programs in the world’s biggest and most profitable market.

Read More »

Abbott Introduces the Next Generation of Influenza A & B and Strep A Assays with Fastest-Ever Time to Molecular Results

Abbott announced today that the U.S. Food and Drug Administration cleared the company’s next-generation Influenza A & B 2 and Strep A 2 molecular assays for point-of-care testing.

Read More »

J&J beats profit estimates, lifts outlook on pharma unit strength

Johnson & Johnson reported slightly better-than-expected third-quarter 2018 profit and raised the company’s full-year forecast.

Read More »

One Drop’s Apple Watch App Points to Trend in Wearable Health Devices

Personalized medicine continues to grow in importance, and having the ability to monitor health data has proven to be a significant desire for people as the number of wearable devices continues to grow.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

October 2018 Focus: Top 50 Pharma, Company of the Year and more!

Subscribe

Ad Right Bottom